28 March 2014
: Case report
Autologous bone marrow mononuclear cell transplantation in Duchenne muscular dystrophy
Unusual setting of medical care, Rare disease, Congenital defects / diseases, Educational Purpose (only if useful for a systematic review or synthesis)
Alok SharmaABCDEFG, Hemangi SaneABCDEFG, Amruta ParanjapeABCDEF, Khushboo BhagwananiBE, Nandini GokulchandranBG, Prerna BadheBGDOI: 10.12659/AJCR.890078
Am J Case Rep 2014; 15:128-134
Abstract
BACKGROUND: Duchenne muscular dystrophy (DMD) is a fatal, genetic, progressive, degenerating muscle disorder. Current treat- ment options are palliative. Newer options of cellular therapy promise to alter the disease process. Preclinical studies have successfully tested myogenic, neurogenic potential and dystrophin expression of bone marrow mononuclear cells.
CASE REPORT: We treated a 9-year-old boy suffering from DMD with serial autologous bone marrow mononuclear cell trans- plantations followed by multidisciplinary rehabilitation. Brooke-Vignos score was 10 and he was wheelchair- bound. Over 36 months, gradual progressive improvement was noticed in muscle strength, ambulation with assistive devices, fine motor movements, Brooke-Vignos score, and functional independence measure score. Nine months after the transplantation, electromyography findings showed development of new normal motor unit potentials of the vastus medialis muscle.
CONCLUSIONS: Magnetic resonance imaging scan of musculoskeletal systems showed no increase in fatty infiltration. This case report provides early investigative findings or the restorative effects of cellular therapy in DMD.
Keywords: Stem Cell Transplantation, Autologous bone marrow mono nuclear cells, Electromyography, Muscular Dystrophy, Duchenne - congenital
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945853
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947512
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946691
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946969
Most Viewed Current Articles
21 Jun 2024 : Case report
96,359
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,229
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
31,248
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,387
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030